PharmaIQ and IDBS: Improving Biopharma R&D Lifecycle Management with Biopharma 4.0

As the Covid-19 pandemic puts a renewed focus on the time and cost of bringing new therapeutics and vaccines to market, this report explores why implementing a biopharma 4.0 approach is necessary for achieving higher flexibility, efficiency and robustness in…